Dusigitumab (MEDI 573) is a human IgG2?? monoclonal antibody engineered to specifically bind to both IGF1 and IGF2. This targeted interaction potentially modulates the activity of these growth factors, which are crucial in cellular processes such as growth, development, and metabolism. Dusigitumab is primarily utilized in research focused on the pathophysiology and therapeutic targeting of diseases influenced by IGF signaling.
Dusigitumab (MEDI 573) is a human IgG2?? monoclonal antibody engineered to specifically bind to both IGF1 and IGF2. This targeted interaction potentially modulates the activity of these growth factors, which are crucial in cellular processes such as growth, development, and metabolism. Dusigitumab is primarily utilized in research focused on the pathophysiology and therapeutic targeting of diseases influenced by IGF signaling.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
